You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tauopathy

Showing 1 - 25 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan Trial (18F-PMPBB3 (APN-1607) PET imaging)

Recruiting
  • Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan
  • 18F-PMPBB3 (APN-1607) PET imaging
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 24, 2022

Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal Dementia Trial in Taoyuan (PMPBB3, AV45)

Recruiting
  • Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal Dementia
  • Taoyuan, Guishan, Taiwan
    Department of Neurology, Chang-Gung memorial Hospital
Oct 3, 2021

4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

Recruiting
  • Corticobasal Degeneration (CBD)
  • +5 more
  • Observational Study
  • San Diego, California
  • +7 more
May 18, 2021

4 Repeat Tauopathy Neuroimaging Initiative

Recruiting
  • Progressive Supranuclear Palsy
  • Corticobasal Degeneration
  • Observational Study
  • San Francisco, California
  • +1 more
Aug 7, 2020

Alzheimer's Disease, Cortical Basal Syndrome, Frontotemporal Dementia Trial in Taoyuan City (F-18)

Completed
  • Alzheimer's Disease
  • +4 more
  • Taoyuan City, Guishan Dist, Taiwan
    Chang Gung Memorial Hospital,Linkou
Oct 17, 2019

Myotonic Dystrophy - Vascular and Cognition

Recruiting
  • Myotonic Dystrophy 1
  • +2 more
  • MRI
  • neuropsychological tests
  • Lille, France
    Hopital Roger Salengro, CHU Lille
Feb 28, 2022

Primary Tauopathies, Corticobasal Degeneration Syndrome, Frontotemporal Lobar Degeneration With Tau Inclusions Trial in San

Terminated
  • Primary Tauopathies
  • +5 more
  • San Francisco, California
    UCSF Memory and Aging Center
Dec 17, 2019

Primary Tauopathy Corticobasal Degeneration Syndrome (CBD) Trial (ABBV-8E12)

No longer available
  • Primary Tauopathy Corticobasal Degeneration Syndrome (CBD)
  • (no location specified)
Aug 16, 2019

Frontotemporal Lobar Degeneration, Alzheimer, Cognitively Normal Trial in Philadelphia ([18F]PI-2620)

Not yet recruiting
  • Frontotemporal Lobar Degeneration
  • +2 more
  • Philadelphia, Pennsylvania
    Perelman Center for Advance Medicine
Jul 13, 2022

Mild Traumatic Brain Injury Trial run by the ([18F]PI-2620)

Recruiting
  • Mild Traumatic Brain Injury
  • Bethesda, Maryland
    Walter Reed National Military Medical Center (WRNMMC)
Apr 14, 2022

Tau PET in Imaging and Cognition: Healthy Adults From 55-90

Recruiting
  • Mild Cognitive Impairment
  • Aging
  • New York, New York
    Columbia University Medical Center
Feb 10, 2022

Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic

Completed
  • Traumatic Brain Injury
  • +2 more
  • Amyvid PET Scan
  • T807 PET scan
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Apr 30, 2019

Circadian Rhythm and Other Factors in Memory Clinic Patients

Not yet recruiting
  • Dementia
  • Questionnaire
  • +3 more
  • Paris, France
  • +1 more
Aug 3, 2023

Human CNS Tau Kinetics in Tauopathies

Completed
  • Progressive Supranuclear Palsy (PSP)
  • +2 more
  • 13C6 Leucine
  • Saint Louis, Missouri
    Washington University in St. Louis School of Medicine
Apr 12, 2022

Alzheimer Trial in Worldwide (LY3372689, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Canoga Park, California
  • +70 more
Jan 18, 2023

Study of Tau Imaging With the Use of [18F]MK-6240 Tracer

Recruiting
  • Alzheimer Disease
  • MK 6240
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 12, 2021

Concussion, Mild Trial in Kansas City (cognitive behavioral therapy for insomnia (CBT-I))

Recruiting
  • Concussion, Mild
  • cognitive behavioral therapy for insomnia (CBT-I)
  • Kansas City, Kansas
    Catherine Siengsukon
May 7, 2021

Healthy Volunteer, Alzheimer, Frontotemporal Dementia Trial in Seoul ([18F]PI-2620)

Completed
  • Healthy Volunteer
  • +3 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 11, 2020

Cognitively Normal, Mild Cognitive Impairment, Alzheimer Trial in Seoul ([18F]PI-2620)

Recruiting
  • Cognitively Normal
  • +2 more
  • Seoul, Korea, Republic of
  • +1 more
Dec 11, 2020

Subjective Cognitive Decline Trial in Berlin (Polyamine supplementation, Placebo supplementation)

Completed
  • Subjective Cognitive Decline
  • Polyamine supplementation
  • Placebo supplementation
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Apr 22, 2021

Subjective Cognitive Decline (SCD) Trial in Berlin (Polyamine, Placebo)

Completed
  • Subjective Cognitive Decline (SCD)
  • Polyamine
  • Placebo
  • Berlin, Germany
    Charité University Medicine Berlin, CCM, Department of Neurology
Apr 22, 2021

Amnestic Mild Cognitive Impairment Trial in Toronto (Psilocybin, Placebo)

Not yet recruiting
  • Amnestic Mild Cognitive Impairment
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Sep 14, 2023

STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder Trial in Aurora, New York (Glycerol Phenylbutyrate 1100

Active, not recruiting
  • STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder
  • Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]
  • Aurora, Colorado
  • +1 more
Jan 24, 2023

Healthy, Alzheimer Trial in Baltimore ([F18]RO-948, [F18]MK-6240, [F18]AV1451)

Withdrawn
  • Healthy
  • Alzheimer Disease
  • [F18]RO-948
  • +2 more
  • Baltimore, Maryland
    John Hopkins Hospital
Feb 7, 2020

18F-PMPBB3 (APN-1607) PET for Progressive Supranuclear Palsy

Recruiting
  • Progressive Supranuclear Palsy
  • 18F-PMPBB3
  • Taoyuan City, Guishan Dist, Taiwan
    Chang Gung Memorial Hospital,Linkou
Sep 8, 2020